AAAAAA

   
Results: 1-21 |
Results: 21
Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study
Authors: Stone, VE Hogan, JW Schuman, P Rompalo, AM Howard, AA Korkontzelou, C Smith, DK
Citation: Ve. Stone et al., Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study, J ACQ IMM D, 28(2), 2001, pp. 124-131
Highly active antiretroviral therapy associated with improved anemia amongHIV-infected women
Authors: Semba, RD Shah, N Klein, RS Mayer, KH Schuman, P Gardner, LI Vlahov, D
Citation: Rd. Semba et al., Highly active antiretroviral therapy associated with improved anemia amongHIV-infected women, AIDS PAT CA, 15(9), 2001, pp. 473-480
Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis
Authors: Vazquez, JA Peng, G Sobel, JD Steele-Moore, L Schuman, P Holloway, W Neaton, JD
Citation: Ja. Vazquez et al., Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis, CLIN INF D, 33(7), 2001, pp. 1069-1075
A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use
Authors: Tashima, KT Hogan, JW Gardner, LI Korkontzelou, C Schoenbaum, EE Schuman, P Rompalo, A Carpenter, CCJ
Citation: Kt. Tashima et al., A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use, CLIN INF D, 33(12), 2001, pp. 2055-2060
HIV infection in families of HIV-positive and 'at-risk' HIV-negative women
Authors: Fiore, T Flanigan, T Hogan, J Cram, R Schuman, P Schoenbaum, E Solomon, L Moore, J
Citation: T. Fiore et al., HIV infection in families of HIV-positive and 'at-risk' HIV-negative women, AIDS CARE, 13(2), 2001, pp. 209-214
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women
Authors: Cohen, RA Boland, R Paul, R Tashima, KT Schoenbaum, EE Celentano, DD Schuman, P Smith, DK Carpenter, CCJ
Citation: Ra. Cohen et al., Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women, AIDS, 15(3), 2001, pp. 341-345
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women - Longitudinal analysis from the HIV epidemiology research study
Authors: Ickovics, JR Hamburger, ME Vlahov, D Schoenbaum, EE Schuman, P Boland, RJ Moore, J
Citation: Jr. Ickovics et al., Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women - Longitudinal analysis from the HIV epidemiology research study, J AM MED A, 285(11), 2001, pp. 1466-1474
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection.
Authors: Cannon, MJ Dollard, SC Smith, DK Klein, RS Schuman, P Rich, JD Vlahov, D Pellett, PE
Citation: Mj. Cannon et al., Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection., N ENG J MED, 344(9), 2001, pp. 637-643
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women
Authors: Ahdieh, L Klein, RS Burk, R Cu-Uvin, S Schuman, P Duerr, A Safaeian, M Astemborski, J Daniel, R Shah, K
Citation: L. Ahdieh et al., Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women, J INFEC DIS, 184(6), 2001, pp. 682-690
Multicenter evaluation of hepatitis C RNA levels among female injection drug users
Authors: Thomas, DL Rich, JD Schuman, P Smith, DK Astemborski, JA Nolt, KR Klein, RS
Citation: Dl. Thomas et al., Multicenter evaluation of hepatitis C RNA levels among female injection drug users, J INFEC DIS, 183(6), 2001, pp. 973-976
The evolution of Candida species and fluconazole susceptibility among oraland vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women
Authors: Sobel, JD Ohmit, SE Schuman, P Klein, RS Mayer, K Duerr, A Vazquez, JA Rompalo, A
Citation: Jd. Sobel et al., The evolution of Candida species and fluconazole susceptibility among oraland vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women, J INFEC DIS, 183(2), 2001, pp. 286-293
Cancer incidence in women with or at risk for HIV
Authors: Phelps, RM Smith, DK Heilig, CM Gardner, LI Carpenter, CCJ Klein, RS Jamieson, DJ Vlahov, D Schuman, P Holmberg, SD
Citation: Rm. Phelps et al., Cancer incidence in women with or at risk for HIV, INT J CANC, 94(5), 2001, pp. 753-757
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus
Authors: Duerr, A Kieke, B Warren, D Shah, K Burk, R Peipert, JF Schuman, P Klein, RS
Citation: A. Duerr et al., Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus, AM J OBST G, 184(4), 2001, pp. 584-590
Effect of HIV infection on menstrual cycle length
Authors: Harlow, SD Schuman, P Cohen, M Ohmit, SE Cu-Uvin, S Lin, XH Anastos, K Burns, D Greenblatt, R Minkoff, H Muderspach, L Rompalo, A Warren, D Young, MA Klein, RS
Citation: Sd. Harlow et al., Effect of HIV infection on menstrual cycle length, J ACQ IMM D, 24(1), 2000, pp. 68-75
Comparison of clinical manifestations of HIV infection among women by riskgroup, CD4(+) cell count, and HIV-1 plasma viral load
Authors: Rompalo, AM Astemborski, J Schoenbaum, E Schuman, P Carpenter, C Holmberg, SD Warren, DL Farzadegan, H Vlahov, D Smith, DK
Citation: Am. Rompalo et al., Comparison of clinical manifestations of HIV infection among women by riskgroup, CD4(+) cell count, and HIV-1 plasma viral load, J ACQ IMM D, 20(5), 1999, pp. 448-454
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women
Authors: Cu-Uvin, S Hogan, JW Warren, D Klein, RS Peipert, J Schuman, P Holmberg, S Anderson, J Schoenbaum, E Vlahov, D Mayer, KH
Citation: S. Cu-uvin et al., Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women, CLIN INF D, 29(5), 1999, pp. 1145-1150
Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection
Authors: Flanigan, TP Hogan, JW Smith, D Schoenbaum, E Vlahov, D Schuman, P Mayer, K
Citation: Tp. Flanigan et al., Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection, CLIN INF D, 29(3), 1999, pp. 608-612
Evolution of vaginal Candida species recovered from human immunodeficiencyvirus-infected women receiving fluconazole prophylaxis: The emergence of Candida glabrata?
Authors: Vazquez, JA Sobel, JD Peng, G Steele-Moore, L Schuman, P Holloway, W Neaton, JD
Citation: Ja. Vazquez et al., Evolution of vaginal Candida species recovered from human immunodeficiencyvirus-infected women receiving fluconazole prophylaxis: The emergence of Candida glabrata?, CLIN INF D, 28(5), 1999, pp. 1025-1031
The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing
Authors: Klein, RS Flanigan, T Schuman, P Smith, D Vlahov, D
Citation: Rs. Klein et al., The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing, INT J TUBE, 3(8), 1999, pp. 681-688
Severe adverse life events and depressive symptoms among women with, or atrisk for, HIV infection in four cities in the United States of America
Authors: Moore, J Schuman, P Schoenbaum, E Boland, B Solomon, L Smith, D
Citation: J. Moore et al., Severe adverse life events and depressive symptoms among women with, or atrisk for, HIV infection in four cities in the United States of America, AIDS, 13(17), 1999, pp. 2459-2468
Criteria for assessing cutaneous anergy in women with or at risk for HIV infection
Authors: Klein, RS Flanigan, T Schuman, P Smith, D Vlahov, D
Citation: Rs. Klein et al., Criteria for assessing cutaneous anergy in women with or at risk for HIV infection, J ALLERG CL, 103(1), 1999, pp. 93-98
Risultati: 1-21 |